FY15 well below expectations; low visibility on turnaround Buy: Results miss as distressed assets returns falls Results missed; reiterating Buy on positive gold outlook FY15 results in line, the worst is yet to come 投资项目推动增长 Beneficiary of low oil prices; Buy Expect more earnings downgrades Significantly shrinking book value;reiterating Sell 高端医械龙头 有效整合释放业绩 FY15 results in line, cost control is the key advantage